1 / 4

Indian Dry Powdered Inhaler Market Size, Share and Forecast 2019-2025

The Indian dry powdered inhaler market is anticipated to grow at a substantial rate of around 7.4% during the forecast period. Major factors that augment the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian dry powdered inhaler market is segmented based on type, application, and end-user. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive dry powdered inhalers are most widely used in the treatment of asthma in children and adults.

pooja99
Download Presentation

Indian Dry Powdered Inhaler Market Size, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Indian Dry Powdered Inhaler Market Size, Share, Trends & Forecast 2019-2025 Request a Free Sample of our Report on Indian Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/indian-dry-powdered-inhaler-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The Indian dry powdered inhaler market is anticipated to grow at a substantial rate of around 7.4% during the forecast period. Major factors that augment the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian dry powdered inhaler market is segmented based on type, application, and end-user. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive dry powdered inhalers are most widely used in the treatment of asthma in children and adults. A Full Report Of Indian Dry Powdered Inhaler Market Is Available At: https://www.omrglobal.com/industry-reports/indian-dry-powdered-inhaler-market Preventive dry powdered inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Based on the type, preventive, reliever, and long-acting bronchodilators Dry Powdered Inhaler is analyzed. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing dry powdered inhalers to cater to a wide range of customers within the region and across the globe. The major players of the Indian dry powdered inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, Propeller Health, Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. Request a Free Sample of our Report on Indian Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/indian-dry-powdered-inhaler-market Indian Dry Powdered Inhaler Market Segmentation

  3. By Type • Preventive Inhaler • Reliever Inhaler • Long Acting Bronchodilators Inhaler By Application • Asthma • Chronic Obstructive Pulmonary Disease (COPD) By End-User • Homecare • Hospitals and Clinics Company Profiles • 3M Co. • Acorda Therapeutics, Inc. • Adamis Pharmaceuticals Corp. • Adherium Ltd. • Aradigm Corp. • AstraZeneca PLC • Beximo Pharmaceuticals Ltd. • Boehringer Ingelheim International GmbH • Cipla Ltd. • GlaxoSmithKline PLC For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/indian-dry-powdered-inhaler-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services.

  4. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related